220 related articles for article (PubMed ID: 10590212)
1. Fractional allele loss indicates distinct genetic populations in the development of squamous cell carcinoma of the head and neck (SCCHN).
Nunn J; Scholes AG; Liloglou T; Nagini S; Jones AS; Vaughan ED; Gosney JR; Rogers S; Fear S; Field JK
Carcinogenesis; 1999 Dec; 20(12):2219-28. PubMed ID: 10590212
[TBL] [Abstract][Full Text] [Related]
2. Fractional allele loss data indicate distinct genetic populations in the development of non-small-cell lung cancer.
Field JK; Neville EM; Stewart MP; Swift A; Liloglou T; Risk JM; Ross H; Gosney JR; Donnelly RJ
Br J Cancer; 1996 Dec; 74(12):1968-74. PubMed ID: 8980398
[TBL] [Abstract][Full Text] [Related]
3. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival.
Field JK; Kiaris H; Risk JM; Tsiriyotis C; Adamson R; Zoumpourlis V; Rowley H; Taylor K; Whittaker J; Howard P
Br J Cancer; 1995 Nov; 72(5):1180-8. PubMed ID: 7577465
[TBL] [Abstract][Full Text] [Related]
4. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity on chromosome 2q: possibly a poor prognostic factor in head and neck cancer.
Ransom DT; Barnett TC; Bot J; de Boer B; Metcalf C; Davidson JA; Turbett GR
Head Neck; 1998 Aug; 20(5):404-10. PubMed ID: 9663668
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity studies on chromosome 17 in head and neck cancer using microsatellite markers.
Adamson R; Jones AS; Field JK
Oncogene; 1994 Jul; 9(7):2077-82. PubMed ID: 8208554
[TBL] [Abstract][Full Text] [Related]
7. Genomic instability in squamous cell carcinoma of the head and neck.
Field JK
Anticancer Res; 1996; 16(4C):2421-31. PubMed ID: 8816845
[TBL] [Abstract][Full Text] [Related]
8. Allelotype of non-small cell lung cancer.
Neville E; Stewart M; Swift A; Liloglou T; Ross H; Gosney J; Donnelly R; Field J
Int J Oncol; 1996 Sep; 9(3):533-9. PubMed ID: 21541547
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite alterations in squamous cell carcinoma of the head and neck - clustering of loss of heterozygosity in a distinct subset.
Ng IO; Xiao L; Lam KY; Yuen PW; Ng M
Oral Oncol; 2000 Sep; 36(5):484-90. PubMed ID: 10964058
[TBL] [Abstract][Full Text] [Related]
10. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity on chromosomes 3p,8p,9p and 17p in the progression of squamous cell carcinoma of the larynx.
Yoo WJ; Cho SH; Lee YS; Park GS; Kim MS; Kim BK; Park WS; Lee JY; Kang CS
J Korean Med Sci; 2004 Jun; 19(3):345-51. PubMed ID: 15201498
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
[TBL] [Abstract][Full Text] [Related]
13. Distinct chromosomal deleted regions defining different subsets of head and neck tumors.
Miracca EC; Yamamoto L; Contado D; de Souza Silva Takimoto M; Kowalski LP; Nagai MA
Diagn Mol Pathol; 2000 Dec; 9(4):229-33. PubMed ID: 11129447
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite analysis and response to chemotherapy in head-and-neck squamous-cell carcinoma.
Blons H; Cabelguenne A; Carnot F; Laccourreye O; de Waziers I; Hamelin R; Brasnu D; Beaune P; Laurent-Puig P
Int J Cancer; 1999 Aug; 84(4):410-5. PubMed ID: 10404095
[TBL] [Abstract][Full Text] [Related]
15. Low microsatellite instability and high loss of heterozygosity rates indicate dominant role of the suppressor pathway in squamous cell carcinoma of head and neck and loss of heterozygosity of 11q14.3 correlates with tumor grade.
Glavac D; Volavsek M; Potocnik U; Ravnik-Glavac M; Gale N
Cancer Genet Cytogenet; 2003 Oct; 146(1):27-32. PubMed ID: 14499693
[TBL] [Abstract][Full Text] [Related]
16. Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.
Dolan K; Garde J; Gosney J; Sissons M; Wright T; Kingsnorth AN; Walker SJ; Sutton R; Meltzer SJ; Field JK
Br J Cancer; 1998 Oct; 78(7):950-7. PubMed ID: 9764589
[TBL] [Abstract][Full Text] [Related]
17. Lip cancer and pre-cancerous lesions harbor TP53 mutations, exhibit allelic loss at 9p, 9q, and 17p, but no BRAFV600E mutations.
Correa GT; Bernardes VF; de Sousa SF; Diniz MG; Salles JM; Souza RP; De-Paula AM; Gomez RS; Gomes CC
Tumour Biol; 2015 Nov; 36(11):9059-66. PubMed ID: 26084614
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
19. Evidence for loss of heterozygosity (LOH) at chromosomes 9p and 17p in oral granular cell tumors: a pilot study.
Gomes CC; Fonseca-Silva T; Gomez RS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):249-53. PubMed ID: 23312918
[TBL] [Abstract][Full Text] [Related]
20. The role of genetic susceptibility in head and neck squamous cell carcinoma.
Abou-Elhamd KE; Habib TN; Moussa AE; Badawy BS
Eur Arch Otorhinolaryngol; 2008 Feb; 265(2):217-22. PubMed ID: 17917736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
